Background: Reduced heart rate variability (HRV) after acute myocardial infarction (AMI) indicates poor prognosis. HRV in patients with uncomplicated coronary artery disease is reduced, and an association with poor prognosis has been suggested. The mechanism of the HRV reduction is not known, but ischemia is a possibility. Aim: To evaluate, in angina patients with no prior AMI, no other disease and drug-free, if complete revascularization and thus important reduction of ischemia by means of PTCA influences HRV. Patients and Methods: Twenty-four-hour Holter recordings were performed at baseline prior to PTCA in 48 patients with angina and in 41 age-matched healthy control subjects. The recording was repeated 1 and 6 months after complete revascularization. In addition, HRV was registered during controlled respiration in the supine and standing positions and during cold pressure test at baseline in all angina patients and controls and in 17 consecutive angina patients 6 months after PTCA. Results: Compared to controls, angina patients had a significantly reduced mean RR interval (p = 0.02), SD (p = 0.003), rMSSD (p = 0.03), pNN50 (p = 0.03), total power (p = 0.003), low- (p = 0.004) and high-frequency peak (p = 0.04), but normal SDNN, SDANN and LF/HF. One and 6 months after PTCA, 42/46 and 32/40 follow-up patients, respectively, were free of angina. Six months after PTCA, there was a significant recovery of vagal modulation seen in the frequency domain during controlled respiration, but only nonsignificant trends in HRV parameters analyzed over 24 h. Conclusion: Patients with uncomplicated angina had reduced HRV, mainly affecting vagal activity, but normal low frequency variability associated with mortality. Complete revascularization caused a partial normalization of vagal modulation indicating that ischemia may be one of but not the only mechanism of the HRV reduction in uncomplicated chronic coronary artery disease.

1.
Cobb LA, Werner JA, Trobaugh GB: Sudden cardiac death. I. A decade’s experience with out-of-hospital resuscitation. Mod Concepts Cardiovasc Dis 1980;49:31–36.
2.
Perper JA, Kuller LH, Cooper M: Arteriosclerosis of coronary arteries in sudden, unexpected deaths. Circulation 1975;51–52(suppl 3):27–33.
3.
Lie JT, Titus JL: Pathology of the myocardium and the conduction system in sudden coronary death. Circulation 1975;51–52(suppl 3):41–52.
4.
Basje WJ, Baba N, Keller M: Pathology of arteriosclerotic heart disease in sudden death. The significance of myocardial infarction. Circulation 1975;51–52(suppl 3):63–69.
5.
Rich MW, Saini JS, Kleiger RE, Carney RM, te Velde A, Freedland KE: Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography. Am J Cardiol 1988;62:714–717.
6.
Airaksinen J, Ikäheimo M, Linnaluoto M, Niemela M, Takkunen JT: Impaired vagal heart rate control in coronary artery disease. Br Heart J 1987;58:592–597.
7.
Hyano J, Sakakibara Y, Yamada M, Ohte N, Fujinami T, Yokoyama K, Matanabe Y, Takata K: Decreased magnitude of heart rate spectral components in coronary artery disease. Its relation to angiographic severity. Circulation 1990;81:1217–1224.
8.
Kleiger RE, Miller JP, Biger JT, Moss AJ, Multicenter Post-Infarction Research Group: Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256–262.
9.
Pomidossi G, Saino A, Perondi R, Gregorini L, Alessio P, Rimini A, Omboni S, Zanchetti A, Mancia G: Impairment of the arterial baroreflex during symptomatic and silent myocardial ischemia in humans. J Am Coll Cardiol 1993;22:1866–1872.
10.
Vardas PE, Kochiadakis GE, Manios EG, Kanoupakis EM, Zouridakis EG, Chlouverakis G: Spectral analysis of heart rate variability before and during episodes of nocturnal ischaemia in patients with extensive coronary artery disease. Eur Heart J 1996;17:388–393.
11.
Mortara A, Specchia G, La Rovere MT, Bigger JT, Marcus FI, Camm JA, Hohnloser SH, Nohara R, Schwartz PJ, on behalf of the ATRAMI Investigators: Patency of infarct-related artery. Effect of restoration of anterograde flow on vagal reflexes. Circulation 1996;93:1114–1122.
12.
Lombardi F, Sandrone G, Pernpruner S, Sala R, Garimold M, Cerruti S, Baselli G, Pagani M, Malliani A: Heart rate variability as an index of sympathovagal interaction after myocardial infarction. Am J Cardiol 1987;60:1230–1245.
13.
Malik M, Farrell T, Cripps T, Camm AJ: Heart rate variability in relation to prognosis after acute myocardial infarction: Selection of optimal processing techniques. Eur Heart J 1989;10:1060–1074.
14.
Malliani A, Pagani M, Lombardi F, Lombardi F: Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84:1482–1492.
15.
Appel MI, Berger RD, Saul JP, Smith JM, Cohen RJ: Beat to beat variability in cardiovascular variables: Noise or music? J Am Coll Cardiol 1989;14:1130–1148.
16.
Ewing DJ, Neilson JMM, Traus R: New method for assessing cardiac parasympathetic activity using 24-hour electrocardiograms. Br Heart J 1984;52:396–402.
17.
Kitney RI, Byrne S, Edmonds ME: Heart rate variability in the assessment of autonomic diabetic neuropathy. Automedica 1982;4:155–167.
18.
Molgaard H, Mickley H, Pless P: Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol 1993;71:1357–1359.
19.
Sandrone G, Mortara A, Torzillo D, La Rovere MT, Malliani A, Lombardi F: Effects of betablockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. Am J Cardiol 1994;74:340–345.
20.
Schweizer MWF, Brachmann J, Kirchner U, Walter-Sack I, Dickhaus H, Metze C, Kubler W: Heart rate variability in time and frequency domains: Effects of gallopamil, nifedipin, and metoprolol compared with placebo. Br Heart J 1993;70:252–258.
21.
Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ: Power spectrum analysis of heart rate fluctuations: A quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220–222.
22.
Binkley PF, Haas GJ, Starling RC, Nunziata E, Hatton PA, Leier CV, Cody RJ: Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol 1993;21:655–661.
23.
Zuanetti G, Latini R, Neilson JMM, Schwartz PJ, Ewing SJ, Antiarrhythmic Drug Evaluation Group (ADEG): Heart rate variability in patients with ventricular arrhythmias: Effect of antiarrhythmic drugs. J Am Coll Cardiol 1991;17:604–612.
24.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability. Standards of measurements, physiological interpretation, and clinic use. Circulation 1996;93:1043–1065.
25.
Niemelä MJ, Airaksinen KEJ, Tahvanainen KUO: Effect of coronary artery bypass grafting on cardiac parasympathetic nervous function. Eur Heart J 1992;13:932–935.
26.
Holmes DR, Davis KB, Mock MB: The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: A report from the Coronary Artery Surgery Study. Circulation 1986;73:1254–1263.
27.
Varnauskas E, European Coronary Surgery Study Group: Twelve-year follow-up of survival in the randomised European coronary surgery study. N Engl J Med 1988;19:332.
28.
Niemelä MJ, Airaksinen KEJ, Ikäheimo MJ: Vagal heart rate control after percutaneous transluminal coronary angioplasty. Eur Heart J 1990;11:320–322.
29.
Desmet W, De Scheerder I, Piessens J: Limited value of exercise testing in the detection of silent restenosis after successful coronary angioplasty. Am Heart J 1995;129:452–459.
30.
Bernardi L, Valle F, Coco M, et al: Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. Cardiovasc Res 1996;32:234–237.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.